Biosensia's Grant

Biosensia raised a round of funding on December 01, 2014. Investors include Horizon 2020.

Biosensia is a point of care in vitro diagnostics company that has a novel point of care platform, RapiPlex, available for licensing. RapiPlex combines technologies to produce a multiplexing point of…

Articles about Biosensia's Grant: